Masaki Gomi, Yu Sakurai, Minami Sato, Hiroki Tanaka, Yumi Miyatake, Koichi Fujiwara, Mizuki Watanabe, Satoshi Shuto, Yuta Nakai, Kota Tange, Hiroto Hatakeyama, Hidetaka Akita. Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine-loaded Lipid Nanoparticles. Adv Healthc Mater, 12(9) e 2202528 (2023) (IF 11.092) https://pubmed.ncbi.nlm.nih.gov/36535635/
Mizuki Doi, Hiroki Tanaka, Takara Ohoto, Naoya Miura, Yu Sakurai, Hiroto Hatakeyama, Hidetaka Akita. Reactivation of anti-cancer immunity by resetting inter-organ crosstalk in immune-suppressive cells with a nano-particulated anti-inflammatory drug. Small (IF 15.153), in press https://onlinelibrary.wiley.com/doi/full/10.1002/smll.202205131
Hiroki Hanaka, Shinya Hagiwara, Daiki Shirane, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Miho Hishinuma, Katsuyuki Chida, Kasumi Sasaki, Etsuo Yonemochi, Keisuke Ueda, Kenjiro Higashi, Kunikazu Moribe, Tkashi Tadokoro, Kastumi Maenaka, Sakura Taneichi, Yuta Nakai, Kota Tange, Yu Sakurai, Hidetaka Akita. Ready-to-Use-type lyophilized lipid nanoparticle formulation for the post-encapsulation of messenger RNA. ACS Nano (IF 15.881), in press https://pubs.acs.org/doi/10.1021/acsnano.2c10501
Invited lecture
Hiroto Hatakeyama. Elucidation of pharmacokinetic factors affecting the efficacy of immune checkpoint inhibitors. JSP/CSPS Joint Symposium, the 143rd Annual Meeting of the Pharmaceutical Society of Japan. March, 25, 2023. Sapporo.